These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22475624)
21. Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study. Rögnvaldsson S; Aspelund T; Thorsteinsdóttir S; Turesson I; Björkholm M; Landgren O; Kristinsson SY Eur J Haematol; 2021 Jul; 107(1):137-144. PubMed ID: 33840154 [TBL] [Abstract][Full Text] [Related]
22. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size. Fisher MA; Wilson JR Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821 [TBL] [Abstract][Full Text] [Related]
23. Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance. Di Troia A; Carpo M; Meucci N; Pellegrino C; Allaria S; Gemignani F; Marbini A; Mantegazza R; Sciolla R; Manfredini E; Scarlato G; Nobile-Orazio E J Neurol Sci; 1999 Mar; 164(1):64-71. PubMed ID: 10385050 [TBL] [Abstract][Full Text] [Related]
24. Short and long-term effect of IVIg in demyelinating neuropathy associated with MGUS, experience of a monocentric study. Théaudin M; Lozeron P; Lacroix C; Chrétien P; Ducot B; Denier C; Adams D Rev Neurol (Paris); 2011 Dec; 167(12):897-904. PubMed ID: 22023823 [TBL] [Abstract][Full Text] [Related]
26. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Bromberg MB; Feldman EL; Albers JW Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342 [TBL] [Abstract][Full Text] [Related]
27. Electrophysiologic features of POEMS syndrome compared with MGUS-related neuropathy. Kim H; Lim YM; Jin JY; Yoon DH; Suh C; Kim SY; Jo JC; Kim KK Muscle Nerve; 2017 Dec; 56(6):E73-E77. PubMed ID: 28472865 [TBL] [Abstract][Full Text] [Related]
28. [Peripheral neuropathy with monoclonal gammopathy]. Meier T; Meyer M Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280 [TBL] [Abstract][Full Text] [Related]
29. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Nobile-Orazio E; Barbieri S; Baldini L; Marmiroli P; Carpo M; Premoselli S; Manfredini E; Scarlato G Acta Neurol Scand; 1992 Jun; 85(6):383-90. PubMed ID: 1379409 [TBL] [Abstract][Full Text] [Related]
30. Electrodiagnostic patterns in MGUS neuropathy. Wilson JR; Stittsworth JD; Fisher MA Electromyogr Clin Neurophysiol; 2001; 41(7):409-18. PubMed ID: 11721296 [TBL] [Abstract][Full Text] [Related]
31. IgM monoclonal gammopathy of undetermined significance: clinicopathologic features with and without IgM-related disorders. Bruehl FK; Mannion P; Barbato E; Nakashima MO; Cook JR Haematologica; 2023 Oct; 108(10):2764-2773. PubMed ID: 37021542 [TBL] [Abstract][Full Text] [Related]
32. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. Yeung KB; Thomas PK; King RH; Waddy H; Will RG; Hughes RA; Gregson NA; Leibowitz S J Neurol; 1991 Oct; 238(7):383-91. PubMed ID: 1660064 [TBL] [Abstract][Full Text] [Related]
33. AAEE case report #17: Peripheral neuropathy in monoclonal gammopathy of undetermined significance. Donofrio PD; Kelly JJ Muscle Nerve; 1989 Jan; 12(1):1-8. PubMed ID: 2546074 [TBL] [Abstract][Full Text] [Related]
34. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy. Ponsford S; Willison H; Veitch J; Morris R; Thomas PK Muscle Nerve; 2000 Feb; 23(2):164-74. PubMed ID: 10639606 [TBL] [Abstract][Full Text] [Related]
35. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975 [TBL] [Abstract][Full Text] [Related]
36. Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies. Galassi G; Tondelli M; Ariatti A; Benuzzi F; Nichelli P; Valzania F Int J Neurosci; 2017 May; 127(5):439-447. PubMed ID: 27188752 [TBL] [Abstract][Full Text] [Related]
37. VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy. Růzicka E; Jech R; Zárubová K; Roth J; Urgosík D Mov Disord; 2003 Oct; 18(10):1192-5. PubMed ID: 14534927 [TBL] [Abstract][Full Text] [Related]
38. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors. Varettoni M; Zibellini S; Capello D; Arcaini L; Rossi D; Pascutto C; Rattotti S; Mangiacavalli S; Pochintesta L; Gotti M; Gaidano G; Cazzola M Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064 [TBL] [Abstract][Full Text] [Related]
39. Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients. Alkhawajah NM; Dunnigan SK; Bril V J Neurol; 2014 Aug; 261(8):1485-91. PubMed ID: 24801490 [TBL] [Abstract][Full Text] [Related]
40. Investigation and Management of Immunoglobulin M- and Waldenström-Associated Peripheral Neuropathies. Tomkins O; Leblond V; Lunn MP; Viala K; Weil DR; D'Sa S Hematol Oncol Clin North Am; 2023 Aug; 37(4):761-776. PubMed ID: 37385714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]